Literature DB >> 8841324

Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening.

J G Terry1, G Howard, M Mercuri, M G Bond, J R Crouse.   

Abstract

BACKGROUND AND
PURPOSE: Apolipoprotein E (apoE) polymorphism affects plasma cholesterol and may influence risk of atherosclerosis. We investigated the association of apoE with carotid artery wall thickening (an index of atherosclerosis) in individuals with and without coronary artery disease (CAD).
METHODS: ApoE phenotypes were resolved in 260 individuals equally represented by angiographically determined CAD case subjects and disease-free control subjects. Carotid artery intima-media thickening (IMT) was evaluated by B-mode ultrasound. Associations of apoE (E2, E3, or E4) with risk factors and IMT were evaluated in general linear models adjusted for age, sex, and CAD status with and without other traditional risk factors.
RESULTS: Total cholesterol (TC) and LDL cholesterol were associated with apoE isoforms. Mean TC and LDL cholesterol were lower in E2 (n = 33) carriers than E3 (n = 155) and E4 (n = 66) carriers (each P < .001). IMT also varied by apoE. E2 carriers had less common carotid IMT than E3 and E4 carriers (P < .01), while internal carotid IMT was less in E2 and E3 carriers than in E4 carriers (P < .02). Bifurcation IMT was not associated with apoE (P = .24). ApoE polymorphism remained associated with common (P < .01) and internal (P < .04) IMT, and the association of apoE with mean IMT of all sites reached significance (P < .04) after adjustment for age, sex, CAD status, TC, LDL cholesterol, HDL cholesterol, triglycerides, diabetes, hypertension, and smoking.
CONCLUSIONS: ApoE polymorphism is associated with segment specific carotid IMT. The association of apoE with carotid IMT was statistically independent of apoE-associated variation in LDL cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841324     DOI: 10.1161/01.str.27.10.1755

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort.

Authors:  T Pohjasvaara; R Mäntylä; H J Aronen; M Leskelä; O Salonen; M Kaste; T Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

2.  Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis.

Authors:  Yi-Chu Liao; Hsiu-Fen Lin; Yuh-Cherng Guo; Ming-Lung Yu; Ching-Kuan Liu; Suh-Hang Hank Juo
Journal:  BMC Med Genet       Date:  2010-06-12       Impact factor: 2.103

Review 3.  Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke.

Authors:  Lavinia Paternoster; Nahara Anáni Martínez González; Steff Lewis; Cathie Sudlow
Journal:  Stroke       Date:  2007-12-06       Impact factor: 7.914

4.  Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia.

Authors:  H Hénon; F Pasquier; I Durieu; J P Pruvo; D Leys
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

5.  Apolipoprotein E Gene Polymorphism and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study.

Authors:  Brett Doliner; Chuanhui Dong; Susan H Blanton; Hannah Gardener; Mitchell S V Elkind; Ralph L Sacco; Ryan T Demmer; Moise Desvarieux; Tatjana Rundek
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-11-02       Impact factor: 2.136

6.  Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy.

Authors:  Michael Tran Duong; Ilya M Nasrallah; David A Wolk; Catherine C Y Chang; Ta-Yuan Chang
Journal:  Front Aging Neurosci       Date:  2021-03-25       Impact factor: 5.750

7.  Apolipoprotein E epsilon4 genotype is independently associated with increased intima-media thickness in a recessive pattern.

Authors:  M Wohlin; J Sundström; Lars Lannfelt; Tomas Axelsson; A C Syvänen; B Andrén; S Basu; L Lind
Journal:  Lipids       Date:  2007-04-11       Impact factor: 1.646

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.